PhilippeWeintraubMD

PubMed

• Psychiatric Consultation of the Incarcerated Patient: Clinical Presentations and Management.
  Sara E. Puening, Philippe Weintraub, Thomas M. Dunn> ;Psychosomatics. 2019 Jul 1
• 175 citations
  Microthinking about micronutrients: a case of transition from obsessions about healthy eating to near-fatal "orthorexia nervosa" and proposed diagnostic criteria.
  Ryan M. Moroze, Thomas M. Dunn, J. Craig Holland, Joel Yager, Philippe Weintraub> ;Psychosomatics. 2015 Jul 1
• Depressive symptoms in pulmonary arterial hypertension: prevalence and association with functional status.
  McCollister DH, Beutz M, McLaughlin V, Rumsfeld J, Masoudi FA, Tripputi M, Yaeger T, Weintraub P, Badesch DB> ;Psychosomatics. 2010-01-01
• 4 citations
  The role of medical school electives in the choice of child psychiatry as a subspecialty.
  Walter Weintraub, S. Michael Plaut, Philippe Weintraub> ;Academic Psychiatry. 1991 Sep 1
• The design and synthesis of purine inhibitors of CDK2. III.
  Shum, P. W., Peet, N. P., Weintraub, P. M., Le, T. B., Zhao, Z., Barbone, F., Cashman, B., Tsay, J., Dwyer, S., Loos, P. C., Powers, E. A., Kropp, K., Wright, P. S., B...> ;Nucleosides Nucleotides Nucleic Acids. 2001 Apr 01
• The synthesis and biological activity of a highly selective adenosine A2a receptor agonist.
  Borcherding, D. R., Lentz, N. L., Weintraub, P. M., Dudley, M. W., Secrest, R., Kastner, P. R., Peet, N. P.> ;Nucleosides Nucleotides. 1999 Oct
• Preparation of 20-(hydroxymethyl)-4-methyl-4-aza-2-oxa-5 alpha-pregnan-3-one as an inhibitor of testosterone 5 alpha-reductase.
  Weintraub, P. M., Blohm, T. R., Laughlin, M.> ;J Med Chem. 1985 Jun 01
• Novel silylated steroids as aromatase inhibitors.
  Burkhart, J. P., Weintraub, P. M., Wright, C. L., Johnston, J. O.> ;Steroids. 1985 Mar 01
• Pharmacological induction of 5 alpha-reductase deficiency in the rat: separation of testosterone-mediated and 5 alpha-dihydrotestosterone-mediated effects.
  Blohm, T. R., Laughlin, M. E., Benson, H. D., Johnston, J. O., Wright, C. L., Schatzman, G. L., Weintraub, P. M.> ;Endocrinology. 1986 Sep 01
• Inhibition of 5-lipoxygenase by substituted 3,4-dihydro-2H-1,4-thiazines.
  Weintraub, P. M., Skoog, M. T., Nichols, J. S., Wiseman, J. S., Huber, E. W., Baugh, L. E., Farrell, A. M.> ;J Pharm Sci. 1989 Nov
• Inhibition of hamster adrenal 11 beta/19-hydroxylase activity.
  Johnston, J. O., Weintraub, P. M., Melby, J. C.> ;Steroids. 1990 Sep
• Conformationally restricted leukotriene receptor antagonists: [(octahydro-2-oxo-7-tetradecylidene-2H-1-benzopyran-8-yl)thio]ace tic acids.
  Gieske, T. H., Sabol, J. S., Weintraub, P. M., Raddatz, R., Cregge, R. J.> ;Pharmacology. 1990
• Steroidal 3,5-dienes.
  Weintraub, P. M., Tiernan, P. L., Benson, H. D., Grunwell, J. F., O'Neal Johnston, J., Petrow, V.> ;J Med Chem. 1976 Dec
• ACEA 1021: flip or flop?
  Petty, M. A., Weintraub, P. M., Maynard, K. I.> ;CNS Drug Rev. 2004
• Synthesis of 21,21-difluoro-3 beta-hydroxy-20-methylpregna-5,20-diene and 5,16,20-triene as potential inhibitors of steroid C17(20) lyase.
  Weintraub, P. M., Holland, A. K., Gates, C. A., Moore, W. R., Resvick, R. J., Bey, P., Peet, N. P.> ;Bioorg Med Chem. 2003 Feb 6
• Novel steroidal vinyl fluorides as inhibitors of steroid C17(20) lyase.
  Burkhart, J. P., Weintraub, P. M., Gates, C. A., Resvick, R. J., Vaz, R. J., Friedrich, D., Angelastro, M. R., Bey, P., Peet, N. P.> ;Bioorg Med Chem. 2002 Apr
• Join now to see all